CClinicalTrials.gg
CompletedNCT01559506Updated Mar 17, 2015Results posted

Air Barrier System Device to Reduce Contamination in Posterior Spine Surgery

An interventional study of Air Barrier System device in Surgery, sponsored by Nimbic Systems, LLC. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-03-17.

Sponsored by Nimbic Systems, LLC · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this study is to determine whether the Air Barrier System (ABS) reduces airborne colony-forming units (e.g. bacteria) present at surgery sites during posterior spinal procedures

Read the detailed description

The ABS is a device that uses localized clean air flow to shield a surgery site from ambient airborne contamination. This study examines the hypothesis that the ABS can reduce the presence of airborne colony-forming units at the surgery site during posterior spinal procedures.

02

Conditions studied

  • Surgery

Keywords

  • CFU
  • surgery site
03

In context

Lead sponsor

Nimbic Systems, LLC is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients undergoing lumbar and cervical laminectomy with instrumentation.

Exclusion criteria

Exclusion Criteria:

  • Active infection
  • Prior prosthesis infection
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
41 participants (actual)

Study arms

  • No intervention
    No device

    Subject does not receive ABS system

  • Experimental
    Air Barrier System device

    Device is deployed adjacent to the surgery site and activated.

    Device: Air Barrier System device

Interventions

  • DeviceAir Barrier System device

    Device is deployed adjacent to the surgery site and activated.

06

What researchers measure

Primary outcomes

  1. CFU Density

    Colony-forming unit density at incision site (CFU/m3)

    Time frame: Surgical case CFU density will be determined at up to 1 month from completion of surgical cases

07

Results

Posted Mar 17, 2015

Participant flow

Participant flow — Overall Study
MilestoneNo DeviceAir Barrier System Device
Started2021
Completed2018
Not completed03

Outcome measures

PrimaryCFU Density

Colony-forming unit density at incision site (CFU/m3)

Time frame:
Surgical case CFU density will be determined at up to 1 month from completion of surgical cases
Reported as:
Mean · CFU/m^3
CFU Density
CFU/m^3No DeviceAir Barrier System Device
CFU Density5.05 (2.45 to 7.65)1.55 (1.08 to 2.01)

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
No Device—0/20 (0%)0/20 (0%)
Air Barrier System Device—0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)No DeviceAir Barrier System DeviceTotal
<=18 years000
Between 18 and 65 years151328
>=65 years5510
Sex: Female, Male
Sex: Female, Male(Participants)No DeviceAir Barrier System DeviceTotal
Female202
Male181836
08

Study locations

1 site
  • Michael E. DeBakey VA Medical Center
    Houston, Texas 77030, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 17, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01559506
Lead sponsor
Nimbic Systems, LLC
Responsible party
Sponsor
First posted
Mar 21, 2012
Start date
Nov 2011
Primary completion
Feb 2015
Completion
Feb 2015
Results posted
Mar 17, 2015
Last update
Mar 17, 2015

Study contacts

Rabih O Darouiche, MD
principal investigator · Baylor College of Medicine
Sean Self
principal investigator · Nimbic Systems

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion